2026-10-19T01:09:20Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/119662026-10-18T21:13:21Zopenairedrivercom_ebyu_10000col_ebyu_10001

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8)Karacin, CengizOksuzoglu, BernaDemirci, AyşeKeskinkılıç, MerveBaytemür, Naziyet KöseYılmaz, FundaSelvi, OğuzhanErdem, DilekAvşar, EsinPaksoy, NailDemir, NeclaGöksu, Sema SezginTürker, SemaBayram, ErtuğrulÇelebi, AbdüssametYılmaz, HaticeKuzu, Ömer FarukKahraman, SedaGökmen, İvoSakin, AbdullahAlkan, AliNayır, ErdinçUğraklı, MuzaferAcar, ÖmerErtürk, İsmailDemir, HacerAslan, FeritSönmez, ÖzlemKorkmaz, TanerCelayir, Özde MelisaKaradağ, İbrahimKayıkçıoğlu, ErkanŞakalar, TeomanÖktem, İlker NihatEren, TülayErul, EnesMocan, Eda EylemerKalkan, ZiyaYıldırım, NilgünErgün, YakupAkagündüz, BaranKarakaya, SerdarKut, EnginTeker, FatihDemirel, Burçin ÇakanKaraboyun, KubilayAlmuradova, ElvinaÜnal, Olçun ÜmitOyman, AbdilkerimIşık, DenizerratumFollowing publication of the original article [1], the authors reported an error in the author name of Enes Erul. Incorrect: Enes Urul Correct: Enes Erul, The original article [1] has been corrected. © 2023, The Author(s).BioMed Central Ltd2023Correctionhttps://rdlopen.rawdatalibrary.net/r/ebyu/11966https://doi.org/10.1186/s12885-023-10662-31471-2407enBMC Cancerinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/11966